Canaccord Remains Positive on Helios and Matheson (HMNY)

Canaccord Genuity maintains Buy on Helios and Matheson Analytics (NASDAQ: HMNY) price target of $15.00.

Analyst Austin Moldow comments "We expect continued rapid growth, with MoviePass having attracted 2M+ subs in 7 months since the pricing change and our forecast calling for 12M subs by 2022. With this audience level, we believe MoviePass should evolve to yield considerable bargaining power, which should drive costs low enough to help flip the currently negative gross margin profile. There are myriad risks, but over time we see opportunity for a large, attractive recurring revenue business."

For an analyst ratings summary and ratings history on Helios and Matheson Analytics click here. For more ratings news on Helios and Matheson Analytics click here.

Shares of Helios and Matheson Analytics closed at $3.37 yesterday.

You May Also Be Interested In

• Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
• HeartFlow (HTFL) PT Raised to $45 at Stifel as Plaque Business Revenue Ramps
• Oculis Holding AG (OCS) Reiterated at Buy by Stifel After CEO Chat